Advertising

Doximity

DOX-N

Analysis and Opinions about DOX-N

Signal
Opinion
Expert
Chart
BUY
BUY
July 21, 2021
Doximity is a new SPAC, a cloud-based social network for MDs offering cloud-based tools that let doctors perform everyday tasks. It's also the ideal platform for advertisers to pitch drugs to doctors. Share have been wild over the past four weeks, but is up 12% this week so far. Buy on pullback. Likes it for being the dominant platform for doctors, connecting over 80% of the nation's docs. It boasts high revenue growth at 78%, and profitability over years as margins expand going forward. They launched a telemedicine growth during last year's lockdown, so that will likely tail off. Net revenue retention rate was up 153% last year. Fabulous fundamentals. But overall, he fears the SPAC scene will collapse from too many of them and of low quality, and that could drag DOX down. Also, DOX's valuation is higher than peers, but that's compensated by a stronger growth profile. When they IPO'd, they offered only 13% of shares to the public, so beware of the end of the lock-up period--buy then. If now, buy a small position.
Show full opinionHide full opinion
Doximity (DOX-N)
July 21, 2021
Doximity is a new SPAC, a cloud-based social network for MDs offering cloud-based tools that let doctors perform everyday tasks. It's also the ideal platform for advertisers to pitch drugs to doctors. Share have been wild over the past four weeks, but is up 12% this week so far. Buy on pullback. Likes it for being the dominant platform for doctors, connecting over 80% of the nation's docs. It boasts high revenue growth at 78%, and profitability over years as margins expand going forward. They launched a telemedicine growth during last year's lockdown, so that will likely tail off. Net revenue retention rate was up 153% last year. Fabulous fundamentals. But overall, he fears the SPAC scene will collapse from too many of them and of low quality, and that could drag DOX down. Also, DOX's valuation is higher than peers, but that's compensated by a stronger growth profile. When they IPO'd, they offered only 13% of shares to the public, so beware of the end of the lock-up period--buy then. If now, buy a small position.
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Doximity(DOX-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 1

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 1

Stockchase rating for Doximity is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Doximity(DOX-N) Frequently Asked Questions

What is Doximity stock symbol?

Doximity is a OTC stock, trading under the symbol DOX-N on the (). It is usually referred to as or DOX-N

Is Doximity a buy or a sell?

In the last year, 1 stock analyst published opinions about DOX-N. 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for Doximity.

Is Doximity a good investment or a top pick?

Doximity was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Doximity.

Why is Doximity stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Doximity worth watching?

In the last year, there was no coverage of Doximity published on Stockchase.

What is Doximity stock price?

On , Doximity (DOX-N) stock closed at a price of $.